Lutz Chelsea S, Schleiss Mark R, Fowler Karen B, Lanzieri Tatiana M
Epidemic Intelligence Service (Dr Lutz), Division of Viral Diseases, National Center for Immunization and Respiratory Diseases (Dr Lutz, Dr Lanzieri), Centers for Disease Control and Prevention, Atlanta, Georgia; Division of Pediatric Infectious Diseases (Dr Schleiss), University of Minnesota Medical School, Minneapolis, Minnesota; and Department of Pediatrics (Dr Fowler), Department of Epidemiology (Dr Fowler), University of Alabama at Birmingham, Birmingham, Alabama.
J Public Health Manag Pract. 2025;31(2):234-243. doi: 10.1097/PHH.0000000000002043. Epub 2024 Sep 3.
Congenital cytomegalovirus (cCMV) infection is the most common infectious cause of birth defects and the leading non-genetic cause of sensorineural hearing loss in the United States. Prior national cCMV infection prevalence estimates were based on one multi-site screening study conducted between 2007 and 2012 and were not adjusted for sociodemographic characteristics, such as maternal race and ethnicity or age.
This study sought to estimate national and state-specific prevalence of cCMV infection in the United States, adjusted for maternal race and ethnicity and maternal age group, by pooling estimates from published studies.
We searched PubMed for U.S. cCMV newborn screening studies conducted between 2003 and 2023. From included studies, we abstracted maternal race and ethnicity- and age group-stratified cCMV prevalence to estimate strata-specific pooled prevalence. We obtained strata-specific weights from live birth data.
Estimated adjusted national and state-specific prevalence estimates from 2018 to 2022.
Four studies (conducted 2004-2005, 2008, 2007-2012, and 2016-2021) were included for data abstraction. Overall, infants born to non-Hispanic Black (9.3 [8.2-10.5] per 1000) or non-Hispanic American Indian and Alaska Native (8.5 [2.1-33.2] per 1000) mothers had the highest cCMV prevalence. The estimated race and ethnicity-adjusted prevalence was 4.6-4.7 per 1000 live births nationally and ranged from 3.9 to 6.5 per 1000 across states from 2018 to 2022. Southern states and Alaska consistently had the highest cCMV prevalence. The estimated maternal age group-adjusted prevalence was 4.3-4.4 per 1000 live births nationally and ranged from 3.8 to 5.1 per 1000 across states from 2018 to 2022.
States with larger proportions of racial and ethnic minorities had higher estimated prevalence of cCMV infection compared to states with larger proportions of White persons. These estimates may be useful for informing cCMV surveillance at the jurisdiction level and developing tailored, culturally relevant education and prevention strategies for persons at higher risk.
先天性巨细胞病毒(cCMV)感染是美国出生缺陷最常见的感染性病因,也是感音神经性听力损失的主要非遗传病因。此前全国性的cCMV感染患病率估计基于2007年至2012年开展的一项多地点筛查研究,且未针对社会人口学特征进行调整,如母亲的种族、族裔或年龄。
本研究旨在通过汇总已发表研究的估计值,估算美国全国及各州特定的cCMV感染患病率,并针对母亲的种族、族裔和年龄组进行调整。
我们在PubMed上搜索了2003年至2023年期间在美国进行的cCMV新生儿筛查研究。从纳入的研究中,我们提取了按母亲种族、族裔和年龄组分层的cCMV患病率,以估算各层特定的合并患病率。我们从活产数据中获取各层特定的权重。
2018年至2022年期间经调整的全国及各州特定患病率估计值。
纳入四项研究(分别于2004 - 2005年、2008年、2007 - 2012年以及2016 - 2021年开展)进行数据提取。总体而言,非西班牙裔黑人母亲(每1000例中有9.3[8.2 - 10.5]例)或非西班牙裔美国印第安人和阿拉斯加原住民母亲(每1000例中有8.5[2.1 - 33.2]例)所生婴儿的cCMV患病率最高。经种族和族裔调整后的全国患病率估计为每1000例活产中有4.6 - 4.7例,2018年至2022年各州范围为每1000例中有3.9至6.5例。南部各州和阿拉斯加的cCMV患病率一直最高。经母亲年龄组调整后的全国患病率估计为每1000例活产中有4.3 - 4.4例,2018年至2022年各州范围为每1000例中有3.8至5.1例。
与白人比例较高的州相比,少数族裔比例较大的州cCMV感染患病率估计更高。这些估计值可能有助于为辖区层面的cCMV监测提供信息,并为高危人群制定针对性的、与文化相关的教育和预防策略。